Artificial intelligence-based multi-omics analysis fuels cancer precision medicine-Reference-Cited by-同舟云学术

Artificial intelligence-based multi-omics analysis fuels cancer precision medicine

Published:2023-01 Issue: Volume:88 Page:187-200
ISSN:1044-579X
Container-title:Seminars in Cancer Biology
language:en
Short-container-title:Seminars in Cancer Biology

Author:

He Xiujing,Liu Xiaowei,Zuo Fengli,Shi Hubing,Jing Jing

Funder

West China Hospital, Sichuan University

National Natural Science Foundation of China

Sichuan University

Shaoxing Bureau of Science and Technology

National Key Research and Development Program of China

Publisher

Elsevier BV

Subject

Cancer Research

Reference220 articles.

1. Integrative methods and practical challenges for single-cell multi-omics;Ma;Trends Biotechnol.,2020

2. Integrating genetic and non-genetic determinants of cancer evolution by single-cell multi-omics;Nam;Nat. Rev. Genet.,2021

3. Towards multi-omics characterization of tumor heterogeneity: a comprehensive review of statistical and machine learning approaches;Lee;Brief. Bioinforma.,2021

4. Multi-omics profiling of the tumor microenvironment: paving the way to precision immuno-oncology;Finotello;Front. Oncol.,2018

5. The pan-cancer landscape of crosstalk between epithelial-mesenchymal transition and immune evasion relevant to prognosis and immunotherapy response;Wang;NPJ Precis. Oncol.,2021

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Artificial intelligence with mass spectrometry-based multimodal molecular profiling methods for advancing therapeutic discovery of infectious diseases;Pharmacology & Therapeutics;2024-11

2. Advancing personalized medicine: Integrating statistical algorithms with omics and nano-omics for enhanced diagnostic accuracy and treatment efficacy;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-10

3. The role of artificial intelligence in the development of anticancer therapeutics from natural polyphenols: Current advances and future prospects;Pharmacological Research;2024-10

4. Immunomodulatory markers and therapies for the management of infant respiratory syncytial virus infection;Expert Review of Anti-infective Therapy;2024-09-13

5. Editorial: Multidimensionally decoding the impact of tumor heterogeneity on immunotherapy responsiveness in gastrointestinal tumors;Frontiers in Immunology;2024-09-03